Zacks Investment Research upgraded shares of AptarGroup (NYSE:ATR) from a hold rating to a buy rating in a report released on Wednesday. They currently have $94.00 price target on the industrial products company’s stock.
According to Zacks, “AptarGroup is well poised for growth given its focus on innovation, solid product pipeline and demand in the Pharma market. The company has implemented a commercial excellence program to boost sales and marketing capability in Beauty + Home segment, which will lead to improved results. Estimates have been stable lately ahead of the company’s Q4 earnings release. The company has positive record of earnings surprises in recent quarters. Moreover, the stock outperformed the industry in the past year.”
ATR has been the topic of a number of other reports. Robert W. Baird reissued a hold rating and issued a $85.00 price objective on shares of AptarGroup in a research note on Thursday, October 12th. KeyCorp reissued a hold rating on shares of AptarGroup in a research note on Friday, October 27th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. AptarGroup currently has an average rating of Hold and an average target price of $83.71.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 21st. Stockholders of record on Wednesday, January 31st will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date of this dividend is Tuesday, January 30th. AptarGroup’s dividend payout ratio is 37.43%.
In related news, CFO Robert Kuhn sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $87.43, for a total transaction of $437,150.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Stephen J. Hagge sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $86.12, for a total value of $2,153,000.00. The disclosure for this sale can be found here. Insiders sold a total of 56,000 shares of company stock worth $4,852,930 over the last three months. 5.30% of the stock is owned by company insiders.
Hedge funds have recently bought and sold shares of the stock. Zions Bancorporation acquired a new position in AptarGroup during the 3rd quarter worth approximately $187,000. Susquehanna International Group LLP raised its stake in AptarGroup by 233.1% during the 2nd quarter. Susquehanna International Group LLP now owns 2,528 shares of the industrial products company’s stock worth $220,000 after buying an additional 4,428 shares during the period. Vident Investment Advisory LLC acquired a new position in AptarGroup during the 3rd quarter worth approximately $221,000. Centiva Capital LP acquired a new position in AptarGroup during the 4th quarter worth approximately $235,000. Finally, Coldstream Capital Management Inc. raised its stake in AptarGroup by 1.1% during the 2nd quarter. Coldstream Capital Management Inc. now owns 2,805 shares of the industrial products company’s stock worth $244,000 after buying an additional 30 shares during the period. 91.40% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2018/02/11/aptargroup-atr-upgraded-at-zacks-investment-research.html.
AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, homecare, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.